Groundbreaking Study Unveils How Influenza A Hijacks Human Cells, Offering New Antiviral Targets

July 20, 2026
Groundbreaking Study Unveils How Influenza A Hijacks Human Cells, Offering New Antiviral Targets
  • A multinational study led by EMBL Hamburg tracks how influenza A virus reprograms infected human cells by directly mapping virus–host protein interactions inside intact cells, using an advanced XL-MS approach combined with AlphaFold modelling, and reports the findings in Nature Microbiology.

  • The methodology could illuminate actionable antiviral targets and potentially be applied to viruses of pandemic relevance, such as H5N1.

  • Paraspeckles, non-membrane nuclear compartments that store proteins and RNA, disassemble during infection, releasing resources that aid viral replication and may weaken the cell’s defenses.

  • Glycoprofiling reveals site-specific changes in HA glycosylation when certain host processing factors are knocked down, outlining how host glycosylation steps shape HA maturation during infection.

  • Functional siRNA screens identified host factors that influence IAV replication, with RAB11A knockdown strongly reducing replication and LAT1 complex components showing context-dependent effects.

  • The early secretory pathway of HA was mapped by XL-MS, showing sequential contacts with ER chaperones, trafficking lectins, and Golgi enzymes, with perturbations in these factors affecting HA maturation and viral replication.

  • The international study, conducted by EMBL and partners, was published on July 20, 2026.

  • The work involved collaboration across Charité, EMBL Hamburg, EMBL Proteomics Core Facility, and CSSB, with distinct components (XL-MS, glycoproteomics, AlphaFold modelling, and microscopy) performed at specialized facilities.

  • Shared infrastructure across institutions supported XL-MS, glycoproteomics, AlphaFold-based modelling, and advanced microscopy, underscoring the multi-disciplinary nature of the effort.

  • The study was led by researchers at EMBL Hamburg and includes contributors from FMP and Charité, with leadership roles for Jan Kosinski and Iuliia Kotova among others.

  • Dismantling paraspeckles may supply components for viral production while dampening cellular immune responses, offering a dual advantage to the virus.

  • The SHVIP approach enriched newly synthesized viral proteins and revealed numerous viral–host cross-links, including interactions with RAB11A, KHSRP, TDP-43, ANP32A/B, nucleosomes, microtubules, and chaperonins, highlighting functional relevance in infection.

Summary based on 8 sources


Get a daily email with more Science stories

More Stories